Update README.md
Browse files
README.md
CHANGED
|
@@ -1,3 +1,45 @@
|
|
| 1 |
-
---
|
| 2 |
-
license: cc-by-4.0
|
| 3 |
-
---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
---
|
| 2 |
+
license: cc-by-4.0
|
| 3 |
+
---
|
| 4 |
+
|
| 5 |
+
# Nanobody (VHH) Affinity Prediction Dataset
|
| 6 |
+
|
| 7 |
+
## Dataset Overview
|
| 8 |
+
|
| 9 |
+
This dataset helps predict the binding affinity between nanobodies (VHH, single-domain antibodies from camelids) and their target antigens. Affinity is a key parameter that measures how strongly an antibody binds to its antigen, usually expressed as dissociation constant (KD) or binding free energy.
|
| 10 |
+
|
| 11 |
+
High affinity is a critical property for therapeutic antibodies, so accurately predicting nanobody affinity is important for antibody engineering and screening.
|
| 12 |
+
|
| 13 |
+
## Data Collection
|
| 14 |
+
|
| 15 |
+
The dataset is based on experimentally measured nanobody-antigen binding affinities. Data is collected from published literature and split based on score (stratified split)
|
| 16 |
+
|
| 17 |
+
## Dataset Structure
|
| 18 |
+
|
| 19 |
+
The dataset is split into training, validation, and test sets.
|
| 20 |
+
|
| 21 |
+
### File Format
|
| 22 |
+
|
| 23 |
+
CSV files contain these columns:
|
| 24 |
+
- `seq`: Nanobody amino acid sequence
|
| 25 |
+
- `score`: Affinity value (typically -log10(KD) where KD is in M), higher values indicate stronger binding affinity
|
| 26 |
+
|
| 27 |
+
## Uses and Limitations
|
| 28 |
+
|
| 29 |
+
### Uses
|
| 30 |
+
- Develop models to predict nanobody affinity
|
| 31 |
+
- Help select and optimize nanobodies
|
| 32 |
+
- Reduce experimental work and speed up drug development
|
| 33 |
+
|
| 34 |
+
### Limitations
|
| 35 |
+
- Differences in affinity measurement methods may cause data variability
|
| 36 |
+
- The same antibody-antigen pair may have different affinity values under different conditions
|
| 37 |
+
- The dataset may not cover all possible nanobody-antigen combinations
|
| 38 |
+
|
| 39 |
+
## Evaluation Metrics
|
| 40 |
+
|
| 41 |
+
Model performance is evaluated using:
|
| 42 |
+
- Spearman correlation
|
| 43 |
+
- R²
|
| 44 |
+
- Root Mean Squared Error (RMSE)
|
| 45 |
+
- Mean Absolute Error (MAE)
|